IBDEI2RB ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,43969,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43969,1,3,0)
;;=3^Creutzfeldt-Jakob Disease,Variant
;;^UTILITY(U,$J,358.3,43969,1,4,0)
;;=4^A81.01
;;^UTILITY(U,$J,358.3,43969,2)
;;=^336701
;;^UTILITY(U,$J,358.3,43970,0)
;;=F05.^^164^2169^13
;;^UTILITY(U,$J,358.3,43970,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43970,1,3,0)
;;=3^Delirium d/t Physiological Cond
;;^UTILITY(U,$J,358.3,43970,1,4,0)
;;=4^F05.
;;^UTILITY(U,$J,358.3,43970,2)
;;=^5003052
;;^UTILITY(U,$J,358.3,43971,0)
;;=R41.0^^164^2169^19
;;^UTILITY(U,$J,358.3,43971,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43971,1,3,0)
;;=3^Disorientation,Unspec
;;^UTILITY(U,$J,358.3,43971,1,4,0)
;;=4^R41.0
;;^UTILITY(U,$J,358.3,43971,2)
;;=^5019436
;;^UTILITY(U,$J,358.3,43972,0)
;;=G31.09^^164^2169^20
;;^UTILITY(U,$J,358.3,43972,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43972,1,3,0)
;;=3^Frontotemporal Disease
;;^UTILITY(U,$J,358.3,43972,1,4,0)
;;=4^G31.09
;;^UTILITY(U,$J,358.3,43972,2)
;;=^329916
;;^UTILITY(U,$J,358.3,43973,0)
;;=G90.3^^164^2169^24
;;^UTILITY(U,$J,358.3,43973,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43973,1,3,0)
;;=3^Multi-System Degeneration of Autonomic Nervous System
;;^UTILITY(U,$J,358.3,43973,1,4,0)
;;=4^G90.3
;;^UTILITY(U,$J,358.3,43973,2)
;;=^5004162
;;^UTILITY(U,$J,358.3,43974,0)
;;=A81.9^^164^2169^28
;;^UTILITY(U,$J,358.3,43974,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43974,1,3,0)
;;=3^Prion Disease
;;^UTILITY(U,$J,358.3,43974,1,4,0)
;;=4^A81.9
;;^UTILITY(U,$J,358.3,43974,2)
;;=^5000414
;;^UTILITY(U,$J,358.3,43975,0)
;;=S06.2X9S^^164^2169^31
;;^UTILITY(U,$J,358.3,43975,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43975,1,3,0)
;;=3^TBI,Diffuse w/ Unspec Duration of LOC,Sequela
;;^UTILITY(U,$J,358.3,43975,1,4,0)
;;=4^S06.2X9S
;;^UTILITY(U,$J,358.3,43975,2)
;;=^5020755
;;^UTILITY(U,$J,358.3,43976,0)
;;=R41.9^^164^2169^25
;;^UTILITY(U,$J,358.3,43976,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43976,1,3,0)
;;=3^Neurocognitive D/O,Unspec
;;^UTILITY(U,$J,358.3,43976,1,4,0)
;;=4^R41.9
;;^UTILITY(U,$J,358.3,43976,2)
;;=^5019449
;;^UTILITY(U,$J,358.3,43977,0)
;;=F01.50^^164^2169^33
;;^UTILITY(U,$J,358.3,43977,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43977,1,3,0)
;;=3^Vascular Dementia w/o Behav Disturb
;;^UTILITY(U,$J,358.3,43977,1,4,0)
;;=4^F01.50
;;^UTILITY(U,$J,358.3,43977,2)
;;=^5003046
;;^UTILITY(U,$J,358.3,43978,0)
;;=F06.31^^164^2170^1
;;^UTILITY(U,$J,358.3,43978,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43978,1,3,0)
;;=3^Depress D/O d/t Anth Med Cond w/ Dep Feat
;;^UTILITY(U,$J,358.3,43978,1,4,0)
;;=4^F06.31
;;^UTILITY(U,$J,358.3,43978,2)
;;=^5003057
;;^UTILITY(U,$J,358.3,43979,0)
;;=F06.32^^164^2170^2
;;^UTILITY(U,$J,358.3,43979,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43979,1,3,0)
;;=3^Depress D/O d/t Anth Med Cond w/ Maj Dep-Like Ep
;;^UTILITY(U,$J,358.3,43979,1,4,0)
;;=4^F06.32
;;^UTILITY(U,$J,358.3,43979,2)
;;=^5003058
;;^UTILITY(U,$J,358.3,43980,0)
;;=F32.0^^164^2170^17
;;^UTILITY(U,$J,358.3,43980,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43980,1,3,0)
;;=3^MDD,Single Episode,Mild
;;^UTILITY(U,$J,358.3,43980,1,4,0)
;;=4^F32.0
;;^UTILITY(U,$J,358.3,43980,2)
;;=^5003521
;;^UTILITY(U,$J,358.3,43981,0)
;;=F32.1^^164^2170^18
;;^UTILITY(U,$J,358.3,43981,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2RB 3745 printed Apr 09, 2024@21:26:57 Page 2
IBDEI2RB ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,43969,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,43969,1,3,0)
+4 ;;=3^Creutzfeldt-Jakob Disease,Variant
+5 ;;^UTILITY(U,$J,358.3,43969,1,4,0)
+6 ;;=4^A81.01
+7 ;;^UTILITY(U,$J,358.3,43969,2)
+8 ;;=^336701
+9 ;;^UTILITY(U,$J,358.3,43970,0)
+10 ;;=F05.^^164^2169^13
+11 ;;^UTILITY(U,$J,358.3,43970,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,43970,1,3,0)
+14 ;;=3^Delirium d/t Physiological Cond
+15 ;;^UTILITY(U,$J,358.3,43970,1,4,0)
+16 ;;=4^F05.
+17 ;;^UTILITY(U,$J,358.3,43970,2)
+18 ;;=^5003052
+19 ;;^UTILITY(U,$J,358.3,43971,0)
+20 ;;=R41.0^^164^2169^19
+21 ;;^UTILITY(U,$J,358.3,43971,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,43971,1,3,0)
+24 ;;=3^Disorientation,Unspec
+25 ;;^UTILITY(U,$J,358.3,43971,1,4,0)
+26 ;;=4^R41.0
+27 ;;^UTILITY(U,$J,358.3,43971,2)
+28 ;;=^5019436
+29 ;;^UTILITY(U,$J,358.3,43972,0)
+30 ;;=G31.09^^164^2169^20
+31 ;;^UTILITY(U,$J,358.3,43972,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,43972,1,3,0)
+34 ;;=3^Frontotemporal Disease
+35 ;;^UTILITY(U,$J,358.3,43972,1,4,0)
+36 ;;=4^G31.09
+37 ;;^UTILITY(U,$J,358.3,43972,2)
+38 ;;=^329916
+39 ;;^UTILITY(U,$J,358.3,43973,0)
+40 ;;=G90.3^^164^2169^24
+41 ;;^UTILITY(U,$J,358.3,43973,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,43973,1,3,0)
+44 ;;=3^Multi-System Degeneration of Autonomic Nervous System
+45 ;;^UTILITY(U,$J,358.3,43973,1,4,0)
+46 ;;=4^G90.3
+47 ;;^UTILITY(U,$J,358.3,43973,2)
+48 ;;=^5004162
+49 ;;^UTILITY(U,$J,358.3,43974,0)
+50 ;;=A81.9^^164^2169^28
+51 ;;^UTILITY(U,$J,358.3,43974,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,43974,1,3,0)
+54 ;;=3^Prion Disease
+55 ;;^UTILITY(U,$J,358.3,43974,1,4,0)
+56 ;;=4^A81.9
+57 ;;^UTILITY(U,$J,358.3,43974,2)
+58 ;;=^5000414
+59 ;;^UTILITY(U,$J,358.3,43975,0)
+60 ;;=S06.2X9S^^164^2169^31
+61 ;;^UTILITY(U,$J,358.3,43975,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,43975,1,3,0)
+64 ;;=3^TBI,Diffuse w/ Unspec Duration of LOC,Sequela
+65 ;;^UTILITY(U,$J,358.3,43975,1,4,0)
+66 ;;=4^S06.2X9S
+67 ;;^UTILITY(U,$J,358.3,43975,2)
+68 ;;=^5020755
+69 ;;^UTILITY(U,$J,358.3,43976,0)
+70 ;;=R41.9^^164^2169^25
+71 ;;^UTILITY(U,$J,358.3,43976,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,43976,1,3,0)
+74 ;;=3^Neurocognitive D/O,Unspec
+75 ;;^UTILITY(U,$J,358.3,43976,1,4,0)
+76 ;;=4^R41.9
+77 ;;^UTILITY(U,$J,358.3,43976,2)
+78 ;;=^5019449
+79 ;;^UTILITY(U,$J,358.3,43977,0)
+80 ;;=F01.50^^164^2169^33
+81 ;;^UTILITY(U,$J,358.3,43977,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,43977,1,3,0)
+84 ;;=3^Vascular Dementia w/o Behav Disturb
+85 ;;^UTILITY(U,$J,358.3,43977,1,4,0)
+86 ;;=4^F01.50
+87 ;;^UTILITY(U,$J,358.3,43977,2)
+88 ;;=^5003046
+89 ;;^UTILITY(U,$J,358.3,43978,0)
+90 ;;=F06.31^^164^2170^1
+91 ;;^UTILITY(U,$J,358.3,43978,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,43978,1,3,0)
+94 ;;=3^Depress D/O d/t Anth Med Cond w/ Dep Feat
+95 ;;^UTILITY(U,$J,358.3,43978,1,4,0)
+96 ;;=4^F06.31
+97 ;;^UTILITY(U,$J,358.3,43978,2)
+98 ;;=^5003057
+99 ;;^UTILITY(U,$J,358.3,43979,0)
+100 ;;=F06.32^^164^2170^2
+101 ;;^UTILITY(U,$J,358.3,43979,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,43979,1,3,0)
+104 ;;=3^Depress D/O d/t Anth Med Cond w/ Maj Dep-Like Ep
+105 ;;^UTILITY(U,$J,358.3,43979,1,4,0)
+106 ;;=4^F06.32
+107 ;;^UTILITY(U,$J,358.3,43979,2)
+108 ;;=^5003058
+109 ;;^UTILITY(U,$J,358.3,43980,0)
+110 ;;=F32.0^^164^2170^17
+111 ;;^UTILITY(U,$J,358.3,43980,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,43980,1,3,0)
+114 ;;=3^MDD,Single Episode,Mild
+115 ;;^UTILITY(U,$J,358.3,43980,1,4,0)
+116 ;;=4^F32.0
+117 ;;^UTILITY(U,$J,358.3,43980,2)
+118 ;;=^5003521
+119 ;;^UTILITY(U,$J,358.3,43981,0)
+120 ;;=F32.1^^164^2170^18
+121 ;;^UTILITY(U,$J,358.3,43981,1,0)
+122 ;;=^358.31IA^4^2
